Abstract:Background- Tetrahydrobiopterin (BH4) is an essential cofactor of endothelial nitric oxide synthase (eNOS). When BH4 levels are decreased, eNOS becomes uncoupled to produce superoxide anion (O-2(-)) instead of NO, which contributes to endothelial dysfunction. Deoxycorticosterone acetate (DOCA) - salt hypertension is characterized by a suppressed plasma renin level due to sodium retention but manifests in eNOS uncoupling; however, how endogenous BH4 regulates blood pressure is unknown. GTP cyclohydrolase I (GTPCH I) is the rate-limiting enzyme for de novo BH4 synthesis. This study tested the hypothesis that endothelium-specific GTPCH I overexpression retards the progression of hypertension through preservation of the structure and function of resistance mesenteric arteries.Methods and Results- During 3 weeks of DOCA-salt treatment, arterial blood pressure was increased significantly in wild-type mice, as determined by radiotelemetry, but this increase was attenuated in transgenic mice with endothelium-specific GTPCH I overexpression (Tg-GCH). Arterial GTPCH I activity and BH4 levels were decreased significantly in wild-type DOCA-salt mice, but both were preserved in Tg-GCH mice despite DOCA-salt treatment. Significant remodeling of resistance mesenteric arteries (approximate to 100-mu m outside diameter) in wild-type DOCA-salt mice exists, evidenced by increased medial cross-sectional area, media thickness, and media-lumen ratio and overexpression of tenascin C, an extracellular matrix glycoprotein that contributes to hypertrophic remodeling; all of these effects were prevented in DOCA-salt - treated Tg-GCH mice. Furthermore, NO-mediated relaxation in mesenteric arteries was significantly improved in DOCA-salt - treated Tg-GCH mice, in parallel with reduced O-2(-) levels. Finally, phosphorylation of eNOS at serine residue 1177 (eNOS-(S1177)), but not its dimer-monomer ratio, was decreased significantly in wild-type DOCA-salt mice compared with sham controls but was preserved in DOCA-salt - treated Tg-GCH mice.Conclusions- These results demonstrate that endothelium-specific GTPCH I overexpression abrogates O-2(-) production and preserves eNOS phosphorylation, which results in preserved structural and functional integrity of resistance mesenteric arteries and lowered blood pressure in low-renin hypertension.

Selective Phosphodiesterase 1 Inhibitor BTTQ Reduces Blood Pressure in Spontaneously Hypertensive and Dahl Salt Sensitive Rats: Role of Peripheral Vasodilation

Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Chronic Reduction in Paraventricular Nucleus (PVN) AT1R Expression by AAV‐mediated Transfer of a Small Hairpin RNA (shrna) Produces a Decrease in Blood Pressure in Spontaneously Hypertensive Rats

Central endothelin ETB receptor activation reduces blood pressure and catecholaminergic activity in the olfactory bulb of deoxycorticosterone acetate-salt hypertensive rats

Functional Inhibition of Urea Transporter UT-B Enhances Endothelial-Dependent Vasodilatation and Lowers Blood Pressure Via L-arginine-endothelial Nitric Oxide Synthase-Nitric Oxide Pathway

Validation of Phosphodiesterase-10 As a Novel Target for Pulmonary Arterial Hypertension Via Highly Selective and Subnanomolar Inhibitors.

Vasodilation and Hypotension of a Novel 3-Benzylquinazolin- 4(3H)-One Derivative Via the Inhibition of Calcium Flux

The Experimental Study of Decrease Blood Pressure with MN9202

Aberrant and D1 and D3 Dopamine Receptor Transregulation in Hypertension

Endothelium-Specific Gtp Cyclohydrolase I Overexpression Attenuates Blood Pressure Progression In Salt-Sensitive Low-Renin Hypertension

Hypotensive Activity of Tetrandrine in Rats

O101 THE ANGIOTENSIN II TYPE 1 RECEPTOR-BIASED AGONIST REDUCES BLOOD PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS AND RESTORES VENTRICULAR HYPERTROPHY BY AFFECTING THE CONNEXIN 43 PATHWAY

Design, synthesis and biological evaluation of dehydroabietic acid derivative as potent vasodilatory agents

Hypotensive activity of tetrandrine in rats. Investigation into its mode of action.

Abstract 5642 Thrombospondin-1, via CD47, Blocks Endothelial-Dependent Arterial Relaxation by Limiting Endothelial Nitric Oxide Synthase Activation

Pharmacological characterization of MT-1207, a novel multitarget antihypertensive agent

Prostanoid TP receptor-mediated impairment of cyclic AMP-dependent vasorelaxation is reversed by phosphodiesterase inhibitors

Dietary Salt Blunts Vasodilation by Stimulating Epithelial Sodium Channels in Endothelial Cells from Salt‐sensitive Dahl Rats

Przewaquinone A inhibits Angiotensin II-induced endothelial diastolic dysfunction activation of AMPK

Inhibition of the Na+/Mg2+ exchanger decreases blood pressure and modulates vascular ERK1/2 and p38 MAP kinase phosphorylation in Ang II-induced hypertensive rats